PHARMACOKINETICS AND DOSAGE REQUIREMENTS OF NETILMICIN IN CYSTIC-FIBROSIS PATIENTS

被引：10

作者：

BOSSO, JA

TOWNSEND, PL

HERBST, JJ

MATSEN, JM

机构：

[1] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1985年 / 28卷 / 06期

关键词：

D O I：

10.1128/AAC.28.6.829

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：829 / 831

页数：3

共 19 条

[1] COMPUTATION OF MODEL-INDEPENDENT PHARMACOKINETIC PARAMETERS DURING MULTIPLE DOSING [J].

BAUER, LA ;

GIBALDI, M .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1983, 72 (08) :978-979

[2] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS [J].

BEAUDRY, PH ;

MARKS, MI ;

MCDOUGALL, D ;

DESMOND, K ;

RANGEL, R .

JOURNAL OF PEDIATRICS, 1980, 97 (01) :144-147

[3]

BRASFIELD D, 1979, PEDIATRICS, V63, P24

[4]

CRAIG WA, 1983, PHARMACOTHERAPY, V3, P305

[5]

Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409

[6] NETILMICIN (NETROMYCIN, SCHERING-PLOUGH) [J].

GUAY, DRP .

DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (02) :83-91

[7]

JAHRE JA, 1978, CLIN PHARMACOL THER, V23, P591

[8]

KEARNS GL, 1982, J PEDIATR-US, V100, P312, DOI 10.1016/S0022-3476(82)80663-X

[9] PHARMACOKINETICS OF TOBRAMYCIN IN CYSTIC-FIBROSIS [J].

KELLY, HB ;

MENENDEZ, R ;

FAN, L ;

MURPHY, S .

JOURNAL OF PEDIATRICS, 1982, 100 (02) :318-321

[10] DISPOSITION OF TOBRAMYCIN IN PATIENTS WITH CYSTIC-FIBROSIS - A PROSPECTIVE CONTROLLED-STUDY [J].

LEVY, J ;

SMITH, AL ;

KOUP, JR ;

WILLIAMSWARREN, J ;

RAMSEY, B .

JOURNAL OF PEDIATRICS, 1984, 105 (01) :117-124

← 1 2 →